Human pharmacokinetics of netilmicin during multiple dosing were studied in serum and in the fluid of skin blisters with two different ratios of interface area to fluid volume. The kinetics in the blisters followed the serum concentration-time curve with a delay but with a similar elimination half-life of 2.4 h. The kinetics in the 40-,lI blisters followed closely the theoretically calculated concentrations of the peripheral compartment of a two-compartment model. In contrast, the concentrations in the 120-,ul blisters increased less rapidly, lower peaks were achieved, and concentrations decreased with a significantly longer delay. A very similar area-specific flow or clearance rate of 1.6 uIl* h-' mm2 was calculated for the interface area between the serum compartment and either the small or large blisters. The observed rapid mass transfer between serum and blister fluid suggests similar oscillations of concentrations in serum and in small interstitial fluid compartments.
Antibiotic penetration into interstitial fluid has been studied in various compartments providing different ratios of surface area for drug exchange to compartment volume. Comparative studies have been performed both in vitro and in animal models of infection (6, 8) . In the study presented here, pharmacokinetics were determined in humans in the fluid of skin blisters with two different ratios of interface area to fluid volume during multiple dosing of netilmicin.
Serum kinetics of aminoglycosides can be simulated by a two-compartment model over a time period of more than 12 h following administration (1, 9) . The parameters of the model are determined such that the concentration-time curve of the central compartment mimics the measured concentrations in serum. However, no anatomical compartments in which the concentration-time curve follows the calculated concentrations of the peripheral compartment of the model have been identified. The kinetics of netilmicin in the fluid of small and large skin blisters were compared with the kinetics calculated for the peripheral compartment of a two-compartment model.
MATERIALS AND METHODS
Study design. The serum kinetics and penetration of netilmicin into interstitial fluid in six healthy male volunteers (body weight, 56 to 66 kg; age, 22 to 26 years) were studied. Doses of 2 mg of netilmicin per kg of lean body weight (doses of 116 to 141 mg) were administered intramuscularly twice and thrice daily over a 1-day period (1 (9) . Pooled human serum was used for the calibration of serum sample measurements, and a mixture of 1 part serum and 3 parts physiological saline was used for the calibration of blister fluid assays. The coefficient of variation of the assay was <4% for concentrations of netilmicin of >0.5 mg/liter, and the sensitivity limit was 0.04 mg/liter (1).
Modeling. A three-compartment model with first-order absorption was used to fit both serum and blister fluid data simultaneously over a 12-h period ( Fig. 1) :
V represents the volume of distribution, C is the concentration, D is the dose, and k is the time constant for exponential absorption from the intramuscular depot. Q, Cl, and F are flow rates, and the indices c, p, and b refer to the central, peripheral, and blister compartments, respectively. Vb was set to 40 and 120 pul for the small and large blisters, respectively. omitted and the flow rate F was set to zero. This reduced model represents a two-compartment model with first-order absorption.
The pharmacokinetic parameters of this model were adapted to the experimental data obtained within the first 12 h by a nonlinear fitting program which minimizes the sum of weighted squared deviations (5) . The weighting function of the squared differences between the observed and predicted values was based on the precision of the assay. Over the concentration range of interest, the relative error of the assay was almost constant. Accordingly, the weighting function was chosen to be inversely proportional to the squares of the absolute concentration values. Figure 2 shows the drug concentrations in serum and blister fluid following administration of 2 mg of netilmicin per kg. The kinetics of the blisters followed the serum concentration-time curve with a delay, but with a similar half-life of The concentration-time curve calculated with this model for the peripheral compartment closely mimicked the kinetics of the 40-,ul blisters, despite the fact that these blister fluid data were not fitted. In contrast, the concentrations in the 120-,ul blisters increased less rapidly, lower peaks were achieved, and concentrations decreased with a significantly longer delay (P < 0.05 [sign test]) compared with the levels calculated for the peripheral compartment.
RESULTS
A three-compartment model used to simultaneously fit concentrations both in serum and in the fluid of either small or large blisters showed close agreement between measured and fitted concentrations (Table 1) . For the small blisters, a flow or clearance rate (F) of 43 ± 2.6 ,ul/h (mean ± standard deviation) was determined, and a rate of 81 ± 5.8 ,ul/h was determined for the large blisters. The larger flow rate determined for the larger blisters relates to the greater interface area, which separated the larger blister fluid compartments from the tissue. The interface area between blister fluid and tissue was 28 mm2 for the small blisters and 50 mm2 for the larger blisters. Dividing the flow rates by the respective interface area, a very similar area-specific flow rate of 1.54 or 1.62 ,ul h-mm2 was calculated for the interface area between serum and small or large blisters, respectively. The 
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time constant, defined as flow rate to volume, was determined to be 1.1 h-' for the small blisters and 0.67 h-1 for the large blisters.
The total protein content of the blister fluid was 17 ± 3 g/liter (mean ± standard deviation). The protein consisted of 61.6% ± 3.0% albumin, 3.9% ± 0.8% o(l-globulin, 7 .0% + 1.7% cx2-globulin, 12.7% + 2.0% n-globulin, and 14.8% ± 1.8% gamma globulin. These percentage values were within the 95% confidence intervals established at our institution for serum, except that the oL1-globulin average percentage of 3.9% measured in blister fluid was above the normal range of 1.4 to 3.3% for serum.
Drug accumulation did occur to only a limited extent during the multiple-dosing regimens. For example, the concentration in the 40-1.l blisters averaged 2.2 ± 0.5 mg/liter 6 h after the first dose and 2.2 ± 0.3 mg/liter 7 h after the second dose during the twice-daily dosing regimen. Samples drawn from the 40-1.l blisters 26 h after the onset of dosing had somewhat higher drug concentrations than did samples obtained within the first dosing interval (Table 1) , reflecting drug accumulation and/or a slight reduction of drug clearance from blisters that were more than 1 day old. During the thrice-daily dosing regimen, 10 h after the third dose, the concentration averaged 0.91 ± 0.28 mg/liter, and during the twice-daily dosing regimen, 14 h after the second dose, the concentration averaged 0.39 ± 0.13 mg/liter.
DISCUSSION
The pharmacokinetics of netilmicin in serum and blister fluid could be fitted closely with a model which simplifies the complex anatomical and physiological situation in vivo by a linear three-compartment model. Because of the good renal clearance of the young participants, the relatively short dosing intervals, and the limited observation period, renal drug accumulation in a deep compartment could be omitted from the model (2, 9) .
Similar area-specific flow rates were observed for small and large blisters interfacing with the central compartment. Thus, the ratio of interface area to volume of the compartment determined the delay by which the concentrations in the blisters followed the concentrations in serum. Compart The calculated kinetics of the peripheral compartment represents the superposition of the kinetics in multiple interstitial spaces with relatively slow drug exchange. However, even in these spaces the concentrations followed the serum kinetics with only a minor delay. Peak and trough levels observed in serum can therefore be considered as representative for well-vascularized interstitial fluid compartments. These considerations suggest that once-daily aminoglycoside treatment of soft tissue infections might result in both high levels in tissue and prolonged periods with subinhibitory concentrations at the site of infection. In contrast, the length of the dosing interval might be less critical at infection sites with low ratios of interface area to volume or in the presence of interface areas with poor vascularization or permeability, resulting in less-pronounced oscillations of drug concentrations within a dosing interval.
